Veeva Systems（1VEEV）株式概要Veeva Systems Inc.は、北米、欧州、アジア太平洋地域、中東、アフリカ、中南米のライフサイエンス業界向けにクラウドベースのソフトウェアを提供している。 詳細1VEEV ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長3/6過去の実績5/6財務の健全性6/6配当金0/6報酬当社が推定した公正価値より41.8%で取引されている 収益は年間13.44%増加すると予測されています 過去1年間で収益は27.3%増加しました リスク分析リスクチェックの結果、1VEEV 、リスクは検出されなかった。すべてのリスクチェックを見る1VEEV Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€149.1515.5% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture05b2016201920222025202620282031Revenue US$5.5bEarnings US$1.6bAdvancedSet Fair ValueView all narrativesVeeva Systems Inc. 競合他社GPISymbol: BIT:GPIMarket cap: €447.2mDiaSorinSymbol: BIT:DIAMarket cap: €3.5bAmplifonSymbol: BIT:AMPMarket cap: €2.9bPro MedicusSymbol: ASX:PMEMarket cap: AU$13.8b価格と性能株価の高値、安値、推移の概要Veeva Systems過去の株価現在の株価US$149.1552週高値US$257.0052週安値US$130.90ベータ0.921ヶ月の変化12.61%3ヶ月変化-4.30%1年変化-38.90%3年間の変化n/a5年間の変化n/aIPOからの変化-24.69%最新ニュースお知らせ • May 30Veeva Systems Announces Falcon Agentic Platform And Standard Agents For Drug DevelopmentVeeva Systems announced Veeva Falcon, an agentic platform and standard agents for life sciences' major drug development processes. Falcon works with Veeva Development Cloud applications in clinical, regulatory, and safety to reduce cost, increase speed, and maintain compliance for biopharmas of all sizes. The initial focus areas are trial master file document intake and quality control, health authority correspondence in regulatory, and safety case triage and intake. Planned for early adopter availability in November 2026, Falcon is part of Veeva AI, Veeva's industry-specific AI solutions for life sciences.お知らせ • May 14Veeva Systems Inc. to Report Q1, 2027 Results on Jun 03, 2026Veeva Systems Inc. announced that they will report Q1, 2027 results After-Market on Jun 03, 2026お知らせ • May 07+ 1 more updateVeeva Systems Inc.(NYSE:VEEV) dropped from Russell Small Cap Comp Growth IndexVeeva Systems Inc.(NYSE:VEEV) dropped from Russell Small Cap Comp Growth Indexお知らせ • May 06Veeva Systems Inc., Annual General Meeting, Jun 17, 2026Veeva Systems Inc., Annual General Meeting, Jun 17, 2026.New Risk • May 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Mar 11Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million.Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million on March 10, 2026. Ostro will operate as an independent unit led by CEO Chase Feiger. Veeva Systems Inc. (NYSE:VEEV) completed the acquisition of Rise Healthcare Tech, Inc from group of shareholders on March 10, 2026.最新情報をもっと見るRecent updatesお知らせ • May 30Veeva Systems Announces Falcon Agentic Platform And Standard Agents For Drug DevelopmentVeeva Systems announced Veeva Falcon, an agentic platform and standard agents for life sciences' major drug development processes. Falcon works with Veeva Development Cloud applications in clinical, regulatory, and safety to reduce cost, increase speed, and maintain compliance for biopharmas of all sizes. The initial focus areas are trial master file document intake and quality control, health authority correspondence in regulatory, and safety case triage and intake. Planned for early adopter availability in November 2026, Falcon is part of Veeva AI, Veeva's industry-specific AI solutions for life sciences.お知らせ • May 14Veeva Systems Inc. to Report Q1, 2027 Results on Jun 03, 2026Veeva Systems Inc. announced that they will report Q1, 2027 results After-Market on Jun 03, 2026お知らせ • May 07+ 1 more updateVeeva Systems Inc.(NYSE:VEEV) dropped from Russell Small Cap Comp Growth IndexVeeva Systems Inc.(NYSE:VEEV) dropped from Russell Small Cap Comp Growth Indexお知らせ • May 06Veeva Systems Inc., Annual General Meeting, Jun 17, 2026Veeva Systems Inc., Annual General Meeting, Jun 17, 2026.New Risk • May 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Mar 11Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million.Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million on March 10, 2026. Ostro will operate as an independent unit led by CEO Chase Feiger. Veeva Systems Inc. (NYSE:VEEV) completed the acquisition of Rise Healthcare Tech, Inc from group of shareholders on March 10, 2026.Reported Earnings • Mar 05Full year 2026 earnings released: EPS: US$5.55 (vs US$4.41 in FY 2025)Full year 2026 results: EPS: US$5.55 (up from US$4.41 in FY 2025). Revenue: US$3.20b (up 16% from FY 2025). Net income: US$908.9m (up 27% from FY 2025). Profit margin: 28% (up from 26% in FY 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.お知らせ • Mar 05Veeva Systems Inc. Provides Earnings Guidance for the First Quarter Ending April 30, 2026 and Fiscal Year Ending January 31, 2027Veeva Systems Inc. provided earnings guidance for the first quarter ending April 30, 2026 and fiscal year ending January 31, 2027. For the quarter, the company expected total revenues between $855 and $858 million. For the year 2027, the company expected total revenues between $3,585 and $3,600 million.お知らせ • Feb 12Veeva Systems Inc. to Report Q4, 2026 Results on Mar 04, 2026Veeva Systems Inc. announced that they will report Q4, 2026 results After-Market on Mar 04, 2026New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Buy Or Sell Opportunity • Jan 27Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 26% to €183. The fair value is estimated to be €230, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.お知らせ • Jan 08Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in ManufacturingVeeva Systems announced a new environmental monitoring (EM) solution to advance quality control (QC) for manufacturing operations. Veeva Environmental Monitoring, a cloud-native application unified with Veeva LIMS, will enable laboratories and manufacturing facilities to schedule, collect, and analyze environmental samples to ensure compliance with GMP and internal sterility standards. Part of Veeva Quality Cloud, Veeva Environmental Monitoring will seamlessly integrate with Veeva quality applications to eliminate data silos and paper-based processes that slow batch release. With unified QC, users can automatically initiate quality events in Veeva QMS, surface procedures from Veeva QualityDocs, and publish critical environmental monitoring data to Veeva Batch Release to optimize the batch release process.お知らせ • Jan 06Veeva Systems Inc. (NYSE:VEEV) announces an Equity Buyback for $2,000 million worth of its shares.Veeva Systems Inc. (NYSE:VEEV) announces an share repurchase program. Under the program, the company will repurchases up to $2,000 million worth of its Class A common stock. The program has a term of 2 years, does not obligate Veeva to acquire a specific number of shares of Class A common stock, and may be canceled or suspended at any time without notice.お知らせ • Dec 13Veeva Systems Inc. Appoints Vipin Kondath as Principal Accounting Officer, Effective December 12, 2025On December 10, 2025, the board of directors of Veeva Systems Inc. appointed Vipin Kondath as its principal accounting officer, effective December 12, 2025. Vipin Kondath, age 50, has served as Veeva’s VP, Corporate Controller since April 2022. From August 2019 to March 2022, he served as Veeva’s Senior Director of Revenue Accounting. Mr. Kondath holds a Bachelor of Commerce degree from Mahatma Gandhi University, and is a chartered accountant from India and a certified public accountant in the State of California. Mr. Kondath also entered into Veeva’s standard form of indemnification agreement and there was no change to his compensation arrangements as a result of the appointment.Buy Or Sell Opportunity • Dec 12Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to €191. The fair value is estimated to be €244, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.お知らせ • Dec 03Veeva Systems Announces the Availability of Veeva Ai Agents for Vault CRM and PromoMatsVeeva Systems announced the availability of Veeva AI Agents for Vault CRM and PromoMats. Veeva AI in the Veeva Vault Platform and deep, specialized AI agents working in Veeva applications deliver practical AI with clear business value. Additional Veeva AI Agents for clinical, regulatory, safety, quality, medical, and commercial are planned for release throughout 2026. Veeva AI Now Available for Vault CRM: Free Text Agent detects and flags potential issues in call notes to ensure accuracy and compliance. With more in-depth call reporting, companies gain the advantage of richer, higher quality customer insights. Voice Agent enables voice input for Vault CRM so it's faster and easier for field teams to capture information and follow-up actions. Pre-call Agent provides insights and suggested actions from relevant data, content, activity, and trends that help field reps prepare for calls. Veeva AI Now available for PromoMats: Quick Check Agent scans content using editorial, brand, market, channel, and compliance guidelines to address issues before medical, legal, regulatory (MLR) review. Content Agent provides context-aware insights into document text and images, answers questions, summarizes content, analyzes visuals, and draws from Quick Check Agent to assist with document review. Veeva AI Agents work seamlessly within Veeva applications and have direct, secure access to data, documents, and workflows and operate within established user access controls, permissions, and audit trails. Customers can also configure and extend Veeva-delivered AI Agents and build their own custom agents with Veeva AI. Veeva Business Consulting provides support for the business process design and change management necessary as companies define new business and process flows among users and agents.Buy Or Sell Opportunity • Nov 25Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to €206. The fair value is estimated to be €258, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.Reported Earnings • Nov 21Third quarter 2026 earnings released: EPS: US$1.44 (vs US$1.15 in 3Q 2025)Third quarter 2026 results: EPS: US$1.44 (up from US$1.15 in 3Q 2025). Revenue: US$811.2m (up 16% from 3Q 2025). Net income: US$236.2m (up 27% from 3Q 2025). Profit margin: 29% (up from 27% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe.お知らせ • Nov 21Veeva Systems Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter Ending January 31, 2026 and Updates Earnings Guidance for the Fiscal Year Ending January 31, 2026Veeva Systems Inc. provides earnings guidance for the fiscal fourth quarter ending January 31, 2026 and updates earnings guidance for the fiscal year ending January 31, 2026. For the quarter, the company expects total revenues between $807 million and $810 million. The company is providing updated guidance for its fiscal year ending January 31, 2026 as follows: Total revenues between $3,166 and $3,169 million.お知らせ • Nov 19Veeva Systems Inc. Announces Executive ChangesOn November 17, 2025, Kristine Diamond, Chief Accounting Officer, informed Veeva Systems Inc. of her decision to resign from her position effective as of December 11, 2025. Upon Ms. Diamond’s departure, Brian Van Wagener, Chief Financial Officer of Veeva, will serve as principal accounting officer until a replacement is named.お知らせ • Oct 31Veeva Systems Inc. to Report Q3, 2026 Results on Nov 20, 2025Veeva Systems Inc. announced that they will report Q3, 2026 results After-Market on Nov 20, 2025Board Change • Oct 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Oct 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 28Second quarter 2026 earnings released: EPS: US$1.23 (vs US$1.06 in 2Q 2025)Second quarter 2026 results: EPS: US$1.23 (up from US$1.06 in 2Q 2025). Revenue: US$789.1m (up 17% from 2Q 2025). Net income: US$200.3m (up 17% from 2Q 2025). Profit margin: 25% (in line with 2Q 2025). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe.お知らせ • Aug 07Veeva Systems Inc. to Report Q2, 2026 Results on Aug 27, 2025Veeva Systems Inc. announced that they will report Q2, 2026 results at 4:00 PM, US Eastern Standard Time on Aug 27, 2025Board Change • Jul 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jun 25Grunenthal Advances Global Regulatory Information Management and Operations with Veeva RIMVeeva Systems announced that Grunenthal is advancing its global regulatory organization with Veeva RIM. By streamlining regulatory information management (RIM) on a single, cloud-based platform, Grunenthal can respond faster to changing regulations and increase process efficiency, from submission planning to health authority submissions to tracking of approvals and decisions. Grunenthal is a leader in pain management focused on addressing unmet medical needs worldwide. With Veeva RIM, the company gains stronger alignment across global regulatory teams, improved data oversight, and the flexibility to scale. By bringing all cross-functional regulatory processes and information together in one application, teams can efficiently respond to regulatory needs and ensure ongoing compliance globally.Board Change • Jun 25Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • May 29First quarter 2026 earnings released: EPS: US$1.40 (vs US$1.00 in 1Q 2025)First quarter 2026 results: EPS: US$1.40 (up from US$1.00 in 1Q 2025). Revenue: US$759.0m (up 17% from 1Q 2025). Net income: US$228.2m (up 41% from 1Q 2025). Profit margin: 30% (up from 25% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.お知らせ • May 29Veeva Systems Inc. Provides Earnings Guidance for the Second Quarter Ending July 31, 2025 and Fiscal Year Ending January 31, 2026Veeva Systems Inc. provided earnings guidance for the second quarter ending July 31, 2025 and updated earnings guidance fiscal year ending January 31, 2026. For the second quarter, the company expects total revenues between $766 million and $769 million. For the full year, the company expects total revenues between $3,090 million and $3,100 million.Board Change • May 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 08Veeva Systems Inc. to Report Q1, 2026 Results on May 28, 2025Veeva Systems Inc. announced that they will report Q1, 2026 results After-Market on May 28, 2025お知らせ • May 06Veeva Systems Inc., Annual General Meeting, Jun 18, 2025Veeva Systems Inc., Annual General Meeting, Jun 18, 2025.株主還元1VEEVIT Healthcare ServicesIT 市場7D8.3%1.1%1.0%1Y-38.9%-8.8%19.4%株主還元を見る業界別リターン: 1VEEV過去 1 年間で-8.8 % の収益を上げたItalian Healthcare Services業界を下回りました。リターン対市場: 1VEEVは、過去 1 年間で19.4 % のリターンを上げたItalian市場を下回りました。価格変動Is 1VEEV's price volatile compared to industry and market?1VEEV volatility1VEEV Average Weekly Movement6.3%Healthcare Services Industry Average Movement6.3%Market Average Movement5.2%10% most volatile stocks in IT Market8.8%10% least volatile stocks in IT Market3.3%安定した株価: 1VEEV 、 Italian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 1VEEVの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20077,928Peter Gassnerwww.veeva.comVeeva Systems Inc.は、北米、欧州、アジア太平洋地域、中東、アフリカ、中南米のライフサイエンス業界向けにクラウドベースのソフトウェアを提供している。製薬・バイオ企業向けのVeeva Vault CRM Suiteで構成されるVeeva Commercial Cloud、複数のチャネルと地域にまたがる医療コンテンツのソースを提供するVeeva Medical、エンドツーエンドのコンテンツおよびデジタル資産管理ソリューションであるVeeva PromoMats、製薬ブランド向けの分析プラットフォームであるVeeva Crossixを提供している。また、顧客参照データソリューションのVeeva OpenData、ディープデータを提供するVeeva Link、非識別化・縦断的な患者データを含むVeeva Compass、アクセスとマルチチャネルのエンゲージメントメトリクスを提供するVeeva CRM Pulseで構成されるVeeva Data Cloudも提供している。さらに、臨床試験の実施を促進するVeeva Clinical Platform、スポンサーやCROが臨床試験を設計・実施するのを支援するVeeva Clinical Data Management、システムとプロセスを統合するVeeva Safety、規制情報管理機能を提供するVeeva RIMで構成されるVeeva Development Cloud、ライフサイエンスや消費者製品業界で使用されるVeeva Quality Cloud、Veeva Business Consultingサービスも提供している。さらに、導入・展開計画、プロジェクト管理、要件分析、ソリューション設計、構成、システム環境管理、展開、ビジネス・業務プロセスの改善・変革に特化したサービス、データ移行やシステム統合に関する技術コンサルティングサービス、トレーニング、システム管理のアウトソーシングなど継続的なマネージドサービスなど、専門的かつサポートサービスも提供している。2009年4月に社名をVeeva Systems Inc.に変更。2007年に法人化され、カリフォルニア州プレザントンに本社を置いている。もっと見るVeeva Systems Inc. 基礎のまとめVeeva Systems の収益と売上を時価総額と比較するとどうか。1VEEV 基礎統計学時価総額€24.39b収益（TTM）€779.11m売上高(TTM)€2.74b31.3xPER（株価収益率8.9xP/Sレシオ1VEEV は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計1VEEV 損益計算書（TTM）収益US$3.20b売上原価US$782.02m売上総利益US$2.41bその他の費用US$1.50b収益US$908.91m直近の収益報告Jan 31, 2026次回決算日Jun 03, 2026一株当たり利益（EPS）5.57グロス・マージン75.53%純利益率28.44%有利子負債／自己資本比率0%1VEEV の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/31 13:43終値2026/05/29 00:00収益2026/01/31年間収益2026/01/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Veeva Systems Inc. 28 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。45 アナリスト機関Joseph VruwinkBairdSaket KaliaBarclaysSean DodgeBMO Capital Markets Equity Research42 その他のアナリストを表示
お知らせ • May 30Veeva Systems Announces Falcon Agentic Platform And Standard Agents For Drug DevelopmentVeeva Systems announced Veeva Falcon, an agentic platform and standard agents for life sciences' major drug development processes. Falcon works with Veeva Development Cloud applications in clinical, regulatory, and safety to reduce cost, increase speed, and maintain compliance for biopharmas of all sizes. The initial focus areas are trial master file document intake and quality control, health authority correspondence in regulatory, and safety case triage and intake. Planned for early adopter availability in November 2026, Falcon is part of Veeva AI, Veeva's industry-specific AI solutions for life sciences.
お知らせ • May 14Veeva Systems Inc. to Report Q1, 2027 Results on Jun 03, 2026Veeva Systems Inc. announced that they will report Q1, 2027 results After-Market on Jun 03, 2026
お知らせ • May 07+ 1 more updateVeeva Systems Inc.(NYSE:VEEV) dropped from Russell Small Cap Comp Growth IndexVeeva Systems Inc.(NYSE:VEEV) dropped from Russell Small Cap Comp Growth Index
お知らせ • May 06Veeva Systems Inc., Annual General Meeting, Jun 17, 2026Veeva Systems Inc., Annual General Meeting, Jun 17, 2026.
New Risk • May 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Mar 11Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million.Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million on March 10, 2026. Ostro will operate as an independent unit led by CEO Chase Feiger. Veeva Systems Inc. (NYSE:VEEV) completed the acquisition of Rise Healthcare Tech, Inc from group of shareholders on March 10, 2026.
お知らせ • May 30Veeva Systems Announces Falcon Agentic Platform And Standard Agents For Drug DevelopmentVeeva Systems announced Veeva Falcon, an agentic platform and standard agents for life sciences' major drug development processes. Falcon works with Veeva Development Cloud applications in clinical, regulatory, and safety to reduce cost, increase speed, and maintain compliance for biopharmas of all sizes. The initial focus areas are trial master file document intake and quality control, health authority correspondence in regulatory, and safety case triage and intake. Planned for early adopter availability in November 2026, Falcon is part of Veeva AI, Veeva's industry-specific AI solutions for life sciences.
お知らせ • May 14Veeva Systems Inc. to Report Q1, 2027 Results on Jun 03, 2026Veeva Systems Inc. announced that they will report Q1, 2027 results After-Market on Jun 03, 2026
お知らせ • May 07+ 1 more updateVeeva Systems Inc.(NYSE:VEEV) dropped from Russell Small Cap Comp Growth IndexVeeva Systems Inc.(NYSE:VEEV) dropped from Russell Small Cap Comp Growth Index
お知らせ • May 06Veeva Systems Inc., Annual General Meeting, Jun 17, 2026Veeva Systems Inc., Annual General Meeting, Jun 17, 2026.
New Risk • May 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Mar 11Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million.Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million on March 10, 2026. Ostro will operate as an independent unit led by CEO Chase Feiger. Veeva Systems Inc. (NYSE:VEEV) completed the acquisition of Rise Healthcare Tech, Inc from group of shareholders on March 10, 2026.
Reported Earnings • Mar 05Full year 2026 earnings released: EPS: US$5.55 (vs US$4.41 in FY 2025)Full year 2026 results: EPS: US$5.55 (up from US$4.41 in FY 2025). Revenue: US$3.20b (up 16% from FY 2025). Net income: US$908.9m (up 27% from FY 2025). Profit margin: 28% (up from 26% in FY 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
お知らせ • Mar 05Veeva Systems Inc. Provides Earnings Guidance for the First Quarter Ending April 30, 2026 and Fiscal Year Ending January 31, 2027Veeva Systems Inc. provided earnings guidance for the first quarter ending April 30, 2026 and fiscal year ending January 31, 2027. For the quarter, the company expected total revenues between $855 and $858 million. For the year 2027, the company expected total revenues between $3,585 and $3,600 million.
お知らせ • Feb 12Veeva Systems Inc. to Report Q4, 2026 Results on Mar 04, 2026Veeva Systems Inc. announced that they will report Q4, 2026 results After-Market on Mar 04, 2026
New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Buy Or Sell Opportunity • Jan 27Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 26% to €183. The fair value is estimated to be €230, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
お知らせ • Jan 08Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in ManufacturingVeeva Systems announced a new environmental monitoring (EM) solution to advance quality control (QC) for manufacturing operations. Veeva Environmental Monitoring, a cloud-native application unified with Veeva LIMS, will enable laboratories and manufacturing facilities to schedule, collect, and analyze environmental samples to ensure compliance with GMP and internal sterility standards. Part of Veeva Quality Cloud, Veeva Environmental Monitoring will seamlessly integrate with Veeva quality applications to eliminate data silos and paper-based processes that slow batch release. With unified QC, users can automatically initiate quality events in Veeva QMS, surface procedures from Veeva QualityDocs, and publish critical environmental monitoring data to Veeva Batch Release to optimize the batch release process.
お知らせ • Jan 06Veeva Systems Inc. (NYSE:VEEV) announces an Equity Buyback for $2,000 million worth of its shares.Veeva Systems Inc. (NYSE:VEEV) announces an share repurchase program. Under the program, the company will repurchases up to $2,000 million worth of its Class A common stock. The program has a term of 2 years, does not obligate Veeva to acquire a specific number of shares of Class A common stock, and may be canceled or suspended at any time without notice.
お知らせ • Dec 13Veeva Systems Inc. Appoints Vipin Kondath as Principal Accounting Officer, Effective December 12, 2025On December 10, 2025, the board of directors of Veeva Systems Inc. appointed Vipin Kondath as its principal accounting officer, effective December 12, 2025. Vipin Kondath, age 50, has served as Veeva’s VP, Corporate Controller since April 2022. From August 2019 to March 2022, he served as Veeva’s Senior Director of Revenue Accounting. Mr. Kondath holds a Bachelor of Commerce degree from Mahatma Gandhi University, and is a chartered accountant from India and a certified public accountant in the State of California. Mr. Kondath also entered into Veeva’s standard form of indemnification agreement and there was no change to his compensation arrangements as a result of the appointment.
Buy Or Sell Opportunity • Dec 12Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to €191. The fair value is estimated to be €244, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
お知らせ • Dec 03Veeva Systems Announces the Availability of Veeva Ai Agents for Vault CRM and PromoMatsVeeva Systems announced the availability of Veeva AI Agents for Vault CRM and PromoMats. Veeva AI in the Veeva Vault Platform and deep, specialized AI agents working in Veeva applications deliver practical AI with clear business value. Additional Veeva AI Agents for clinical, regulatory, safety, quality, medical, and commercial are planned for release throughout 2026. Veeva AI Now Available for Vault CRM: Free Text Agent detects and flags potential issues in call notes to ensure accuracy and compliance. With more in-depth call reporting, companies gain the advantage of richer, higher quality customer insights. Voice Agent enables voice input for Vault CRM so it's faster and easier for field teams to capture information and follow-up actions. Pre-call Agent provides insights and suggested actions from relevant data, content, activity, and trends that help field reps prepare for calls. Veeva AI Now available for PromoMats: Quick Check Agent scans content using editorial, brand, market, channel, and compliance guidelines to address issues before medical, legal, regulatory (MLR) review. Content Agent provides context-aware insights into document text and images, answers questions, summarizes content, analyzes visuals, and draws from Quick Check Agent to assist with document review. Veeva AI Agents work seamlessly within Veeva applications and have direct, secure access to data, documents, and workflows and operate within established user access controls, permissions, and audit trails. Customers can also configure and extend Veeva-delivered AI Agents and build their own custom agents with Veeva AI. Veeva Business Consulting provides support for the business process design and change management necessary as companies define new business and process flows among users and agents.
Buy Or Sell Opportunity • Nov 25Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to €206. The fair value is estimated to be €258, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
Reported Earnings • Nov 21Third quarter 2026 earnings released: EPS: US$1.44 (vs US$1.15 in 3Q 2025)Third quarter 2026 results: EPS: US$1.44 (up from US$1.15 in 3Q 2025). Revenue: US$811.2m (up 16% from 3Q 2025). Net income: US$236.2m (up 27% from 3Q 2025). Profit margin: 29% (up from 27% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe.
お知らせ • Nov 21Veeva Systems Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter Ending January 31, 2026 and Updates Earnings Guidance for the Fiscal Year Ending January 31, 2026Veeva Systems Inc. provides earnings guidance for the fiscal fourth quarter ending January 31, 2026 and updates earnings guidance for the fiscal year ending January 31, 2026. For the quarter, the company expects total revenues between $807 million and $810 million. The company is providing updated guidance for its fiscal year ending January 31, 2026 as follows: Total revenues between $3,166 and $3,169 million.
お知らせ • Nov 19Veeva Systems Inc. Announces Executive ChangesOn November 17, 2025, Kristine Diamond, Chief Accounting Officer, informed Veeva Systems Inc. of her decision to resign from her position effective as of December 11, 2025. Upon Ms. Diamond’s departure, Brian Van Wagener, Chief Financial Officer of Veeva, will serve as principal accounting officer until a replacement is named.
お知らせ • Oct 31Veeva Systems Inc. to Report Q3, 2026 Results on Nov 20, 2025Veeva Systems Inc. announced that they will report Q3, 2026 results After-Market on Nov 20, 2025
Board Change • Oct 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Oct 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 28Second quarter 2026 earnings released: EPS: US$1.23 (vs US$1.06 in 2Q 2025)Second quarter 2026 results: EPS: US$1.23 (up from US$1.06 in 2Q 2025). Revenue: US$789.1m (up 17% from 2Q 2025). Net income: US$200.3m (up 17% from 2Q 2025). Profit margin: 25% (in line with 2Q 2025). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe.
お知らせ • Aug 07Veeva Systems Inc. to Report Q2, 2026 Results on Aug 27, 2025Veeva Systems Inc. announced that they will report Q2, 2026 results at 4:00 PM, US Eastern Standard Time on Aug 27, 2025
Board Change • Jul 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 25Grunenthal Advances Global Regulatory Information Management and Operations with Veeva RIMVeeva Systems announced that Grunenthal is advancing its global regulatory organization with Veeva RIM. By streamlining regulatory information management (RIM) on a single, cloud-based platform, Grunenthal can respond faster to changing regulations and increase process efficiency, from submission planning to health authority submissions to tracking of approvals and decisions. Grunenthal is a leader in pain management focused on addressing unmet medical needs worldwide. With Veeva RIM, the company gains stronger alignment across global regulatory teams, improved data oversight, and the flexibility to scale. By bringing all cross-functional regulatory processes and information together in one application, teams can efficiently respond to regulatory needs and ensure ongoing compliance globally.
Board Change • Jun 25Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • May 29First quarter 2026 earnings released: EPS: US$1.40 (vs US$1.00 in 1Q 2025)First quarter 2026 results: EPS: US$1.40 (up from US$1.00 in 1Q 2025). Revenue: US$759.0m (up 17% from 1Q 2025). Net income: US$228.2m (up 41% from 1Q 2025). Profit margin: 30% (up from 25% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
お知らせ • May 29Veeva Systems Inc. Provides Earnings Guidance for the Second Quarter Ending July 31, 2025 and Fiscal Year Ending January 31, 2026Veeva Systems Inc. provided earnings guidance for the second quarter ending July 31, 2025 and updated earnings guidance fiscal year ending January 31, 2026. For the second quarter, the company expects total revenues between $766 million and $769 million. For the full year, the company expects total revenues between $3,090 million and $3,100 million.
Board Change • May 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 08Veeva Systems Inc. to Report Q1, 2026 Results on May 28, 2025Veeva Systems Inc. announced that they will report Q1, 2026 results After-Market on May 28, 2025
お知らせ • May 06Veeva Systems Inc., Annual General Meeting, Jun 18, 2025Veeva Systems Inc., Annual General Meeting, Jun 18, 2025.
